S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Bladder Cancer Case Control Study of Arsenic in Water
- Status
- COMPLETED
- Phase
- N/A
Suramin in Treating Patients With Recurrent Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
R115777 in Treating Patients With Advanced Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE3
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1